Nicholas B. Pike
Atherosclerosis Department
GlaxoSmithKline
Stevenage
UK
Name/email consistency: high
- Flushing out the role of GPR109A (HM74A) in the clinical efficacy of nicotinic acid. Pike, N.B. J. Clin. Invest. (2005)
- Identification of a nicotinic acid receptor: is this the molecular target for the oldest lipid-lowering drug?. Pike, N.B., Wise, A. Curr. Opin. Investig. Drugs (2004)